"When patients feel seen, supported, and educated, they're more likely to stick with their treatment and see meaningful results." Starting GLP-1 treatment can be a life-changing decision, but it often comes with more surprises than patients expect
Participants taking the highest approved 25mg dose lost an average of 17% of their starting body weight over 64 weeks, when used alongside a reduced-calorie diet and increased physical activity, and treatment was taken as intended
Usually, sermorelin acetate injections are self-administered by the patient
Reported side effects are uncommon and typically mild: Localized redness, swelling, or irritation at the injection site
S.DingX
Long-term safety considerations from four years of data The SELECT trial provided the longest safety data available for semaglutide at the weight loss dose